Unfractionated Heparin for the Treatment of Venous Thromboembolism: Best Practices and Areas of Uncertainty

被引：19

作者：

Cuker, Adam ^{[1
,2
]}

机构：

[1] Univ Penn, Dept Med, Philadelphia, PA 19104 USA

[2] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA

来源：

SEMINARS IN THROMBOSIS AND HEMOSTASIS | 2012年 / 38卷 / 06期

关键词：

heparin; unfractionated heparin; venous thromboembolism; dosing; laboratory monitoring; PARTIAL THROMBOPLASTIN TIME; MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; CONTINUOUS INTRAVENOUS HEPARIN; ACUTE PULMONARY-EMBOLISM; MYOCARDIAL-INFARCTION; ANTICOAGULANT-THERAPY; SUBCUTANEOUS HEPARIN; INITIAL TREATMENT; ANTITHROMBIN-III;

D O I：

10.1055/s-0032-1319770

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Nearly 100 years after its discovery, unfractionated heparin (UFH) remains a widely used anticoagulant for the treatment of venous thromboembolism (VTE) and several other thrombotic and prothrombotic conditions. Decades of experience and investigation have contributed to our knowledge of this agent, but crucial questions regarding its optimal use in clinical practice remain unanswered. This review will critically examine the evidence for dosing and laboratory monitoring of UFH in the management of VTE, and highlight areas of uncertainty and future research.

引用

页码：593 / 599

页数：7

共 50 条

[41] Enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in renally impaired ICU patients
DeBiase, Christopher
Giuliano, Christopher A.
Doshi, Mitesh
Ganoff, Michelle
Alexander Paxton, Renee
[J]. PHARMACOTHERAPY, 2021, 41 (05): : 424 - 429
[42] Venous Thromboembolism Prophylaxis with Enoxaparin Versus Unfractionated Heparin in Patients with Low Body Weight
Kaylor, David Michael
Wade, Regan Merrell
Chappell, Kathryn Brinkley
Niemann, Meredith Huff
VanArsdale, Vanessa Marie
[J]. PLASMATOLOGY, 2023, 17
[43] Low-molecular-weight or Unfractionated Heparin in Venous Thromboembolism: The Influence of Renal Function
Trujillo-Santos, Javier
Schellong, Sebastian
Falga, Conxita
Zorrilla, Vanessa
Gallego, Pedro
Barron, Manuel
Monreal, Manuel
[J]. AMERICAN JOURNAL OF MEDICINE, 2013, 126 (05): : 425 - U149
[44] Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism - an overview
Bernardi, E
Piccioli, A
Oliboni, G
Zuin, R
Girolami, A
Prandoni, P
[J]. THROMBOSIS AND HAEMOSTASIS, 2000, 84 (01) : 22 - 26
[45] DETERMINANTS OF THE ANTITHROMBOTIC RESPONSE TO A STANDARDIZED DOSE OF INTRAVENOUS UNFRACTIONATED HEPARIN IN PATIENTS WITH VENOUS THROMBOEMBOLISM
PRINS, MH
YOUNG, E
HIRSH, J
[J]. THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 768 - 768
[46] Utilization review of unfractionated heparin in the treatment of venous thromboembolic disease
Chung, KK
Browne, WT
[J]. CRITICAL CARE MEDICINE, 2001, 29 (12) : A160 - A160
[47] HEPARIN AND VENOUS THROMBOEMBOLISM
KAKKAR, VV
[J]. THROMBOSIS AND HAEMOSTASIS, 1977, 38 (01) : 227 - 227
[48] Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism
Kearon, Clive
Ginsberg, Jeffrey S.
Julian, Jim A.
Douketis, James
Solymoss, Susan
Ockelford, Paul
Jackson, Sharon
Turpie, Alexander G.
MacKinnon, Betsy
Hirsh, Jack
Gent, Michael
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (08): : 935 - 942
[49] Venous Thromboembolism Prophylaxis in Neurocritical Care Patients: Are Current Practices, Best Practices?
Sauro, K. M.
Soo, A.
Kramer, A.
Couillard, P.
Kromm, J.
Zygun, D.
Niven, D. J.
Bagshaw, S. M.
Stelfox, H. T.
[J]. NEUROCRITICAL CARE, 2019, 30 (02) : 355 - 363
[50] Venous Thromboembolism Prophylaxis in Neurocritical Care Patients: Are Current Practices, Best Practices?
K. M. Sauro
A. Soo
A. Kramer
P. Couillard
J. Kromm
D. Zygun
D. J. Niven
S. M. Bagshaw
H. T. Stelfox
[J]. Neurocritical Care, 2019, 30 : 355 - 363

← 1 2 3 4 5 →